Drugplain

Tarpeyo 4 mg/1

budesonide · CAPSULE, DELAYED RELEASE · Calliditas Therapeutics AB

No Recall History
Plain English

Tarpeyo is a delayed-release oral corticosteroid capsule containing 4 mg of budesonide that is used to reduce proteinuria (protein loss in urine) in patients with IgA nephropathy, a type of kidney disease. This prescription medication works by reducing inflammation in the kidneys to help slow kidney disease progression.

Key Facts

Brand Name
Tarpeyo
Generic Name
budesonide
NDC Code (Product)
81749-004
Manufacturer
Calliditas Therapeutics AB
Strength
4 mg/1
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Marketing Status
Application #
NDA215935
Drug Class
Corticosteroid [EPC]
Marketing Start
12/15/2021

Recall History

No Recall History

Frequently Asked Questions

What is Tarpeyo used for?

Tarpeyo is a delayed-release oral corticosteroid capsule containing 4 mg of budesonide that is used to reduce proteinuria (protein loss in urine) in patients with IgA nephropathy, a type of kidney disease. This prescription medication works by reducing inflammation in the kidneys to help slow kidney disease progression.

Is Tarpeyo a controlled substance?

Tarpeyo is not classified as a controlled substance by the DEA.

What is the generic name for Tarpeyo?

The generic name for Tarpeyo is budesonide. There are 12 other brand versions of budesonide.

What is the NDC code for Tarpeyo 4 mg/1?

The NDC (National Drug Code) for Tarpeyo 4 mg/1 is 81749-004, listed by Calliditas Therapeutics AB.

Product NDC

81749-004

Package NDC

81749-004-01

Other Budesonide Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)